Impact of neoadjuvant therapy on gut microbiome in patients with resectable/borderline resectable pancreatic ductal adenocarcinoma: Gut microbiome in pancreatic cancer during neoadjuvant therapy

导出原文传递

翻译打印收藏纠错

作者： Takaori A. ^[1] ; Hashimoto D. ^[2] ; Ikeura T. ^[3] ; Ito T. ^[4] ; Nakamaru K. ^[5] ; Masuda M. ^[6] ; Nakayama S. ^[7] ; Yamaki S. ^[8] ; Yamamoto T. ; Fujimoto K. ; Matsuo Y. ; Akagawa S. ; Ishida M. ; Yamaguchi K. ; Imoto S. ; Hirota K. ; Uematsu S. ; Satoi S. ; Sekimoto M. ; Naganuma M.

作者单位： Third Department of Internal Medicine Kansai Medical University ^[1] Department of Surgery Kansai Medical University ^[2] Department of Immunology and Genomics Graduate School of Medicine Osaka Metropolitan University ^[3] Department of Human Stress Response Science Kansai Medical University ^[4] Department of Pediatrics Kansai Medical University ^[5] Department of Pathology Osaka Medical and Pharmaceutical University ^[6] Division of Clinical Genome Research Advanced Clinical Research Center The Institute of Medical ^[7] Division of Health Medical Intelligence Human Genome Center The Institute of Medical Science The ^[8]

关键词 Chemotherapy Gut microbiome Neoadjuvant therapy Pancreatic cancer

发布时间 2023-09-19

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交